Study Stopped
Covid-19
Rehabilitation of Adolescents Living With Chronic Fatigue
1 other identifier
interventional
3
1 country
1
Brief Summary
Previous studies have shown that health-related quality of life (HRQoL) in adolescents living with chronic fatigue syndrome (CFS/ME) is low if compared with healthy adolescents and adolescents living with other chronic diseases. Effective strategies to improve HRQoL in this group are still lacking. Recently we have observed HRQoL in a group of Norwegian adolescents with CFS/ME (not yet published), which is the background for a new study where we have planned an intervention with health promoting dialogues between patient and nurse, as a strategy to improve HRQoL. In this study we have also opened to include adolescents with other chronic fatigue diagnosis with similar challenges in follow-up as in CFS/ME.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2019
CompletedFirst Posted
Study publicly available on registry
November 26, 2019
CompletedStudy Start
First participant enrolled
December 6, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2020
CompletedJune 25, 2020
June 1, 2020
5 months
November 19, 2019
June 23, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life (HRQoL)
assessed by PedsQL Generic Core scale 4.0
1 year
Secondary Outcomes (4)
Fatigue Questionnaire
1 year
Mood and Feelings Questionnaire
1 year
Self-reported follow-up, School functioning and participation in Leisure activities
1 year
EQ-5D-5L
1 year
Study Arms (2)
Health promoting dialogue in addition to treatment as usual
EXPERIMENTALHealth promoting dialogues in addition to follow-up from primary and secondary health care, and from schools, which is individually customized due to fatigue and other symptoms present.
Treatment as usual
ACTIVE COMPARATORFollow-up from primary and secondary health care, and from Schools, which is individually customized due to fatigue and other symptoms present..
Interventions
Health promoting dialogues based on the salutogenic theory, focusing on resources within and around the individual, and on coping strategies. Seven individual dialogues for each participant, individually adapted due to the fatigue. The intervention is offered in the participants home or at the local hospital, dependent on the participants fatigue and what is preferred.
Follow-up from primary and secondary health care, and from schools.
Eligibility Criteria
You may qualify if:
- chronic fatigue as main symptom (including but not limited to diagnostic codes ICD-10 G93.3 CFS/ME, F48.0 Neurasthenia, R53 Fatigue)
- having undergone an interdisciplinary diagnostic evaluation at The Children's Clinic or at The Fatigue and CFS/ME Outpatient Clinic, St. Olavs hospital during the period 1.8.2019 - 1.4.2020.
- being a pupil or wishing to be a pupil.
You may not qualify if:
- not Norwegian speaking
- for any reason unable to read and answer a questionnaire
- for any reason unable to take part in the health promoting dialogues
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- St. Olavs Hospitallead
- Norwegian University of Science and Technologycollaborator
- Trondheim Kommunecollaborator
Study Sites (1)
Barne og ungdomsklinikken (Children's Clinic)
Trondheim, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Elisabeth Selvaag, md phd
St. Olavs Hospital
- PRINCIPAL INVESTIGATOR
Torstein Baade Rø, md phd
Norwegian University of Science and Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2019
First Posted
November 26, 2019
Study Start
December 6, 2019
Primary Completion
April 30, 2020
Study Completion
April 30, 2020
Last Updated
June 25, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
The standard consent form used in this study is developed by the regional ethical committee, and does not include consent to make individual participant data available for other researchers.